Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.590
+0.020 (0.78%)
At close: Apr 28, 2026, 4:00 PM EDT
2.650
+0.060 (2.32%)
After-hours: Apr 28, 2026, 7:29 PM EDT
Nautilus Biotechnology Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Nautilus Biotechnology stock has a target of 4.00, which predicts an increase of 54.44% from the current stock price of 2.59.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 27, 2026.
Analyst Ratings
According to 1 stock analyst, the rating for Nautilus Biotechnology is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $2.5 → $4 | Strong Buy | Maintains | $2.5 → $4 | +54.44% | Feb 27, 2026 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $2.25 → $1.75 | Hold → Strong Sell | Downgrades | $2.25 → $1.75 | -32.43% | Dec 5, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +131.66% | Jun 27, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Initiates $5 → $3 | Strong Buy → Hold | Initiates | $5 → $3 | +15.83% | Jun 3, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $6 | Hold | Reiterates | $6 | +131.66% | Aug 3, 2023 |
Financial Forecast
Revenue This Year
714.00K
Revenue Next Year
7.80M
from 714.00K
Increased by 992.86%
EPS This Year
-0.56
from -0.47
EPS Next Year
-0.56
from -0.56
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 945,000 | 11.0M | |||
| Avg | 714,000 | 7.8M | |||
| Low | 490,000 | 4.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 1,444.1% | |||
| Avg | - | 992.9% | |||
| Low | - | 558.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.56 | -0.46 | |
| Avg | -0.56 | -0.56 | |
| Low | -0.56 | -0.65 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.